Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coagulation Defect; Bleeding”

1,130 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,130 results

Testing effectiveness (Phase 2)Ended earlyNCT00154427
What this trial is testing

Use of Activated Recombinant Human Factor VII in Cardiac Surgery

Who this might be right for
Acquired Bleeding DisorderCardiac Surgery Requiring Cardiopulmonary Bypass
Novo Nordisk A/S 172
Post-approval studies (Phase 4)Study completedNCT05326139
What this trial is testing

Topical Tranexamic Acid Application in Rhinoplasty

Who this might be right for
Ecchymosis; EyelidEdemaRhinoplasty
Baskent University 50
Testing effectiveness (Phase 2)UnknownNCT06190145
What this trial is testing

Teriflunomide for Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 40
Testing effectiveness (Phase 2)Study completedNCT03395210
What this trial is testing

Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Principia Biopharma, a Sanofi Company 86
Not applicableStudy completedNCT00710619
What this trial is testing

Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 52
Testing effectiveness (Phase 2)Ended earlyNCT05086744
What this trial is testing

Basket Study to Assess Efficacy, Safety and PK of Iptacopan (LNP023) in Autoimmune Benign Hematological Disorders

Who this might be right for
Immune Thrombocytopenia (ITP)Cold Agglutinin Disease (CAD)
Novartis Pharmaceuticals 19
Large-scale testing (Phase 3)Not Yet RecruitingNCT07597395
What this trial is testing

ATRA for Management of Primary ITP

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 192
Not applicableActive Not RecruitingNCT07560007
What this trial is testing

The Bleeding Assessment Tool (BAT)

Who this might be right for
Bleeding DisorderVon Willebrand Disease (VWD)
Children's Hospital Medical Center, Cincinnati 1,000
Large-scale testing (Phase 3)Study completedNCT02281201
What this trial is testing

Study of a Prothrombin Complex Concentrate for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Japanese Subjects

Who this might be right for
Acute Major BleedingReversal of Coagulopathy
CSL Behring 11
Testing effectiveness (Phase 2)Looking for participantsNCT05003986
What this trial is testing

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change DiseaseImmunoglobulin A Nephropathy+2 more
Travere Therapeutics, Inc. 67
Testing effectiveness (Phase 2)Active Not RecruitingNCT07733037
What this trial is testing

Fecal Microbiota Transplantation for Steroid-resistant or Relapsed Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Peking University People's Hospital 42
Large-scale testing (Phase 3)Active Not RecruitingNCT00319228
What this trial is testing

Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate

Who this might be right for
Antithrombin III Deficiency
Grifols Biologicals, LLC 30
Testing effectiveness (Phase 2)Looking for participantsNCT07234019
What this trial is testing

Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 160
Not applicableLooking for participantsNCT04800458
What this trial is testing

Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis

Who this might be right for
ThrombocytopeniaImmune ThrombocytopeniaMyelodysplasia
University Hospital, Bordeaux 225
Not applicableStudy completedNCT05224388
What this trial is testing

Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.

Who this might be right for
COVID-19Deep Vein ThrombosisAnticoagulants and Bleeding Disorders+1 more
University Hospital, Ghent 813
Testing effectiveness (Phase 2)UnknownNCT04481282
What this trial is testing

The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 40
Large-scale testing (Phase 3)Study completedNCT01480180
What this trial is testing

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 186
Large-scale testing (Phase 3)Study completedNCT05220878
What this trial is testing

Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP

Who this might be right for
Idiopathic Thrombocytopenic Purpura
AO GENERIUM 160
Large-scale testing (Phase 3)UnknownNCT06155955
What this trial is testing

Comparison of Outcomes Between Low Dose Emicizumab and Factor VIII in Clinically Severe Hemophilia A

Who this might be right for
Severe Hemophilia A Without InhibitorJoint Bleed
Chulalongkorn University 15
Not applicableLooking for participantsNCT04119908
What this trial is testing

Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases

Who this might be right for
Von Willebrand DiseasesGlanzmann Thrombasthenia
University Hospital, Lille 400
Next Page